Translational Development Acquisition Corp. (TDACU) Cash from Financing Activities (2024 - 2026)

Translational Development Acquisition (TDACU) has 3 years of Cash from Financing Activities data on file, last reported at $300000.0 in Q1 2026.

• Quarterly Cash from Financing Activities changed N/A year-over-year to $300000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $175.8 million (changed N/A YoY) and the FY2025 annual result came in at $200000.0, down 99.89% from the prior year.
• Cash from Financing Activities advanced to $300000.0 in Q1 2026, from $100000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $175.3 million in Q4 2024 to a low of $100000.0 in Q4 2025.
• A 3-year average of $44.0 million and a median of $246250.0 in 2024 frame the typical range for Cash from Financing Activities.
• The widest YoY moves for Cash from Financing Activities: up 99.94% in 2025, down 99.94% in 2025.
• Tracing TDACU's Cash from Financing Activities over 3 years: stood at $175.3 million in 2024, then plunged by 99.94% to $100000.0 in 2025, then surged by 200.0% to $300000.0 in 2026.
• The last three Cash from Financing Activities figures came in at $300000.0 (Q1 2026), $100000.0 (Q4 2025), and $175.3 million (Q4 2024), per Business Quant data.